Gilead Sciences (GILD) Minority Interest (2009 - 2026)
Gilead Sciences posted quarterly Minority Interest of -$84.0 million for Q1 2026, little changed year-on-year from -$84.0 million in Q1 2025, and little changed on a QoQ basis from -$84.0 million in Q4 2025.
Gilead Sciences (GILD) has 18 years of Minority Interest data on file, last reported at -$84.0 million in Q1 2026.
- For the quarter ending Q1 2026, Minority Interest changed 0.0% year-over-year to -$84.0 million; the trailing twelve-month figure through Mar 2026 stood at -$84.0 million (changed 0.0% YoY), and the FY2025 full-year result was -$84.0 million, changed 0.0% from the prior year.
- Minority Interest for Q1 2026 stood at -$84.0 million, roughly flat from -$84.0 million in the prior quarter.
- Across five years, Minority Interest topped out at -$12.0 million in Q1 2022 and bottomed at -$84.0 million in Q4 2023.
- The 5-year median for Minority Interest is -$84.0 million (2023), against an average of -$66.0 million.
- The widest annual swing landed in 2022, when Minority Interest slumped 2500.0%; it then changed 0.0% in 2024.
- A 5-year view of Minority Interest shows it stood at -$31.0 million in 2022, then slumped by 170.97% to -$84.0 million in 2023, then changed by 0.0% to -$84.0 million in 2024, then changed by 0.0% to -$84.0 million in 2025, then changed by 0.0% to -$84.0 million in 2026.
- The last three Minority Interest figures came in at -$84.0 million (Q1 2026), -$84.0 million (Q4 2025), and -$84.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.00 Mn |
| Dec 31, 2025 | -84.00 Mn |
| Sep 30, 2025 | -84.00 Mn |
| Jun 30, 2025 | -84.00 Mn |
| Mar 31, 2025 | -84.00 Mn |
| Dec 31, 2024 | -84.00 Mn |
| Sep 30, 2024 | -84.00 Mn |
| Jun 30, 2024 | -84.00 Mn |
| Mar 31, 2024 | -84.00 Mn |
| Dec 31, 2023 | -84.00 Mn |
| Sep 30, 2023 | -72.00 Mn |
| Jun 30, 2023 | -64.00 Mn |
| Mar 31, 2023 | -58.00 Mn |
| Dec 31, 2022 | -31.00 Mn |
| Sep 30, 2022 | -24.00 Mn |
| Jun 30, 2022 | -21.00 Mn |
| Mar 31, 2022 | -12.00 Mn |
| Dec 31, 2021 | -5.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 7.00 Mn |
| Mar 31, 2021 | 12.00 Mn |
| Dec 31, 2020 | 19.00 Mn |
| Sep 30, 2020 | 26.00 Mn |
| Jun 30, 2020 | 115.00 Mn |
| Mar 31, 2020 | 112.00 Mn |
| Dec 31, 2019 | 125.00 Mn |
| Sep 30, 2019 | 132.00 Mn |
| Jun 30, 2019 | 135.00 Mn |
| Mar 31, 2019 | 140.00 Mn |
| Dec 31, 2018 | 147.00 Mn |
| Sep 30, 2018 | 146.00 Mn |
| Jun 30, 2018 | 62.00 Mn |
| Mar 31, 2018 | 60.00 Mn |
| Dec 31, 2017 | 59.00 Mn |
| Sep 30, 2017 | 409.00 Mn |
| Jun 30, 2017 | 414.00 Mn |
| Mar 31, 2017 | 476.00 Mn |
| Dec 31, 2016 | 476.00 Mn |
| Sep 30, 2016 | 492.00 Mn |
| Jun 30, 2016 | 579.00 Mn |
| Mar 31, 2016 | 621.00 Mn |
| Dec 31, 2015 | 579.00 Mn |
| Sep 30, 2015 | 530.00 Mn |
| Jun 30, 2015 | 347.00 Mn |
| Mar 31, 2015 | 408.00 Mn |
| Dec 31, 2014 | 393.00 Mn |
| Sep 30, 2014 | 297.39 Mn |
| Jun 30, 2014 | 338.71 Mn |
| Mar 31, 2014 | 314.87 Mn |
| Dec 31, 2013 | 375.00 Mn |
| Sep 30, 2013 | 308.86 Mn |
| Jun 30, 2013 | 251.38 Mn |
| Mar 31, 2013 | 240.24 Mn |
| Dec 31, 2012 | 241.13 Mn |
| Sep 30, 2012 | 146.52 Mn |
| Jun 30, 2012 | 81.27 Mn |
| Mar 31, 2012 | 50.47 Mn |
| Dec 31, 2011 | 128.49 Mn |
| Sep 30, 2011 | 116.44 Mn |
| Jun 30, 2011 | 164.49 Mn |
| Mar 31, 2011 | 229.11 Mn |
| Dec 31, 2010 | 258.11 Mn |
| Sep 30, 2010 | 172.46 Mn |
| Mar 31, 2010 | 160.68 Mn |
| Dec 31, 2009 | 138.09 Mn |
| Sep 30, 2009 | 105.62 Mn |
| Jun 30, 2009 | 124.12 Mn |